A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
Active, not recruiting · NCT05453903 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-25 | NCT05453903 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
32 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.